These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
644 related items for PubMed ID: 7982251
1. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension. Fagan TC, Haggert BE, Liss C. Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251 [Abstract] [Full Text] [Related]
2. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study. Lefebvre J, Poirier L, Archambault F, Jewell D, Reed CV, Lacourcière Y. Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524 [Abstract] [Full Text] [Related]
3. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial. Kim SH, Chung WY, Zo JH, Kim MA, Chang HJ, Cho YS, Youn TJ, Chae IH, Choi DJ, Gwak JJ, Lee HY, Park JS, Kang HJ, Kim YJ, Kim HS. Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099 [Abstract] [Full Text] [Related]
4. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators. Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [Abstract] [Full Text] [Related]
5. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S, Caglar N, Canberk A, Deger N, Demirtas M, Dortlemez H, Kiliccioglu B, Kozan O, Ovunc K, Turkoglu C. Curr Med Res Opin; 2003 Sep; 19(3):226-37. PubMed ID: 12803737 [Abstract] [Full Text] [Related]
6. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension. Germino FW. Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484 [Abstract] [Full Text] [Related]
7. Efficacy and safety of enalapril versus extended-release nifedipine for the treatment of mild-to-moderate essential hypertension: a multicenter 22-week study. Multicenter Cooperative Study Group. Leon AS. Clin Ther; 1993 Sep; 15(6):1094-107. PubMed ID: 8111807 [Abstract] [Full Text] [Related]
8. [Multicenter comparative study of felodipine-ER and nifedipine-OROS in the treatment of mild-to-moderate arterial hypertension]. Batlouni M, Leite Luna R, Castro I, Silveira Sbissa A, Armaganijan D, Chaves Junior Hde C, Nobre F, Pereira da Cunha C. Arq Bras Cardiol; 1996 Apr; 66(4):247-51. PubMed ID: 8935693 [Abstract] [Full Text] [Related]
15. Comparative effects of amlodipine and felodipine ER on office and ambulatory blood pressure in patients with mild to moderate hypertension. Danish Multicentre Group. Høegholm A, Wiinberg N, Rasmussen E, Nielsen PE. J Hum Hypertens; 1995 Mar; 9 Suppl 1():S25-8. PubMed ID: 7783110 [Abstract] [Full Text] [Related]
16. Results of a multicenter, 8-week, parallel-group, randomized,double-blind, double-dummy, Phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension. Park S, Chung N, Kwon J, Yoon JH, Kim YJ, Han DS, Kim HS. Clin Ther; 2005 Apr; 27(4):441-50. PubMed ID: 15922817 [Abstract] [Full Text] [Related]